title: Changes in pulmonary vascular function after acute methionine loading in normal men.
abstract: Elevated blood levels of Hcy (homocysteine) are associated with endothelial dysfunction in the systemic and coronary arterial beds. We wished to know if similar changes could be detected in the pulmonary circulation, using non-invasive tests. We studied ten normal young men aged 23-31 years, in whom acute hyperhomocysteinaemia was induced by oral ingestion of methionine. Cardiopulmonary exercise testing [including measurement of exhaled breath NO (nitric oxide)] was performed on two occasions, with and without methionine loading. In addition, blood samples for vWf (von Willebrand factor) and factor VIIIc were taken as markers of endothelial function. After oral methionine, plasma Hcy increased from 11.8 +/- 3.1 to 31.2 +/- 10.3 micromol/l (values are means +/- S.D.; P < 0.0001), whereas there was no increase after placebo. After exercise there was an increase in V(NO) (NO production) and circulating plasma levels of vWf and factor VIIIc, but these were similar in the two tests. Exercise time, HR (heart rate) and BP (blood pressure) responses and P V(O2) (peak achieved O2 uptake) were also similar in the two tests. V(E) (expiratory minute ventilation)/ V(CO2) (CO2 production) was similar in the two groups at rest (methionine, 31.9 +/- 3.9; placebo, 30.5 +/- 3.9; P = 0.11), but increased during exercise after methionine (at peak, 32.2 +/- 4.6 compared with 29.9 +/- 2.8; P = 0.016). P(ETCO2) (end-tidal partial pressure of CO2) was also similar in the two groups at rest (35.1 +/- 2.9 compared with 36.8 +/- 3.2; P = 0.11), but decreased throughout the methionine test (peak 34.1 +/- 4.4 compared with 36.7 +/- 3.5; P = 0.006). V(E) vs V(CO2) slope also increased in the methionine test (25.2 +/- 2.4 compared with 22.8 +/- 2.3; P = 0.003). In conclusion, small, but consistent and significant, changes in respiratory gas exchange were seen after methionine loading, compatible with a V / Q (ventilation/perfusion) mismatch due to pulmonary vascular endothelial dysfunction.
authors.affiliation: Department of Medicine, Royal Victoria Hospital, Belfast BT12 6BA, Northern Ireland, U.K.
authors.forename: Conor
authors.initials: C
authors.lastname: O'Dochartaigh
authors.forename: Hean
authors.initials: H
authors.lastname: Ong
authors.forename: Sharon
authors.initials: S
authors.lastname: Lovell
authors.forename: Ronan
authors.initials: R
authors.lastname: Donnelly
authors.forename: Colm
authors.initials: C
authors.lastname: Hanratty
authors.forename: Marshall
authors.initials: M
authors.lastname: Riley
authors.forename: Michael
authors.initials: M
authors.lastname: Frenneaux
authors.forename: Ian
authors.initials: I
authors.lastname: Young
authors.forename: Paul
authors.initials: P
authors.lastname: Nicholls
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D001944:Breath Tests; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005080:Exercise Test; D005169:Factor VIII / Q000032:analysis; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000503:physiopathology*; D008297:Male; D008715:Methionine; D009569:Nitric Oxide / Q000032:analysis; D011652:Pulmonary Circulation; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D015415:Biomarkers; D014841:von Willebrand Factor; D009569:Nitric Oxide; D005169:Factor VIII; D008715:Methionine